# Study of Pomaglumetad and Methamphetamine

> **NCT03106571** · PHASE1 · TERMINATED · sponsor: **University of California, Los Angeles** · enrollment: 19 (actual)

## Conditions studied

- Methamphetamine Use Disorder

## Interventions

- **DRUG:** Pomaglumetad methionil
- **DRUG:** Placebo
- **DRUG:** Methamphetamine

## Key facts

- **NCT ID:** NCT03106571
- **Lead sponsor:** University of California, Los Angeles
- **Sponsor class:** OTHER
- **Phase:** PHASE1
- **Study type:** INTERVENTIONAL
- **Status:** TERMINATED
- **Start date:** 2017-08-01
- **Primary completion:** 2020-07-31
- **Final completion:** 2020-07-31
- **Target enrollment:** 19 (ACTUAL)
- **Why stopped:** Deemed unable to enroll targeted participants in part due to COVID-19 shut downs
- **Last updated:** 2020-09-01

## Collaborators

- [object Object]

## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT03106571

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT03106571, "Study of Pomaglumetad and Methamphetamine". Retrieved via AI Analytics 2026-06-02 from https://api.ai-analytics.org/clinical/NCT03106571. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*